Language: Spanish
References: 14
Page: 137-155
PDF size: 7917.44 Kb.

Text Extraction

No abstract

REFERENCES

1. De Angelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, DawsonTL Jr. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Invest Dermatol Symp Proc 2005; 10: 295-7.

2. Piérard-Franchimont C, Xhauflaire-Uhoda E, Piérard E. Revisiting dandruff. Int J Cosmet Sci 2006; 28: 311-8.

3. De Angelis YM, Saunders CW, Johnstone KR, Reeder NL, Coleman CG, Kaczvinsky JR Jr et al. Isolation and Expression of a Malassezia globosa Lipase Gene, LIP1. J Invest Dermatol 2007; 127: 2138-46.

4. Harding CR, Moore AE, Rogers JS, Meldrum H, Scott AE, McGlone FP. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res 2002; 294: 221-30.

5. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 261-6.

6. Elewski BE. Safe and Effective Treatment of Seborrheic Dermatitis. Cutis 2009; 83: 333-8.

7. Schwartz JR. Treatment of seborrheic dermatitis of the scalp. J Cosmet Dermatol 2007; 6 (Suppl.1): 18-22.

8. Waldroup W, Scheinfeld N. Medicated shampoos for the treatment of seborrheic dermatitis. J Drugs Dermatol 2008; 7: 699-703.

9. Seité S, Paries J, Reygagne P, Hamidou Z, Jouanique C, Perez-Pala G, Rougier A. A lipohydroxyacid- containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis. J Cosmet Dermatol 2009; 8: 108-13.

10. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-78.

11. Gueniche A, Benyacoub J, Blum S, Breton L, Castiel I. Probiotics for Skin Benefits. Nutritional Cosmetics: Beauty from Within (2009 Edition). Eds A Tabor and RM Blair. William Andrew Inc, 2009. 421-39.

12. Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J Clin Invest 2003; 112: 648-51.

13. Gueniche A, Benyacoub J, Philippe D, Bastien P, Kusis N, Breton L et al. Lactobacillus paracasei CNMC I-2116 (ST11) inhibits substance Pinduced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol 2010; 20: 731-7.

14. Chen SC, Yeung J, Chren MM. Scalpdex: a quality of life instrument for scalp dermatitis. Arch Dermatol 2002;138: 803-7.